Abstract
Early rhythm control strategies may improve cardiovascular outcomes for patients with atrial fibrillation. Dofetilide is one effective strategy, but its risk of QT prolongation and torsades de pointes necessitates a hospital-based initiation. Detecting patients who do not have sufficient “repolarization reserve” to safely tolerate dofetilide would alter shared decision-making regarding rhythm control strategies using this drug.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have